Breast cancer surgery trend changes since the introduction of BRCA1/2 mutation screening: A retrospective cohort analysis of 158 mutation carriers treated at a single institution

Annals of Surgical Oncology

Volumn 18, Issue 3, 2011, Pages 745-751

  Mislowsky, Angela ^a,b   Domchek, Susan ^a,b   Stroede, Cecilia ^a,b   Bergey, Meredith R ^a,b   Sonnad, Seema S ^b   Wu, Liza ^b   Tchou, Julia ^a,b,c  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c Perelman Center for Advanced Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

ADULT; ARTICLE; BILATERAL MASTECTOMY; BREAST CANCER; BREAST RECONSTRUCTION; BREAST SURGERY; CANCER DIAGNOSIS; CANCER SURGERY; CLINICAL EVALUATION; CONTROLLED STUDY; ETHNICITY; FEMALE; FREE SKIN GRAFT; GENE MUTATION; GENETIC SCREENING; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MASTECTOMY; OVARIECTOMY; PARTIAL MASTECTOMY; PROPHYLAXIS; RETROSPECTIVE STUDY; TREND STUDY; TUMOR SUPPRESSOR GENE; TUMOR VOLUME;

ADULT; BRCA1 PROTEIN; BRCA2 PROTEIN; BREAST NEOPLASMS; COHORT STUDIES; EARLY DETECTION OF CANCER; FEMALE; GENETIC TESTING; HETEROZYGOTE; HUMANS; MASTECTOMY; MIDDLE AGED; MUTATION; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE;

EID: 79952788599     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-010-1381-9     Document Type: Article

References (13)

1. Tuttle T, Habermann E, Grund E, et al. Increasing use of contralateral prophylactic mastectomy among breast cancer patients: A trend toward more aggressive surgical treatment. Ann Surg Oncol. 2007;14(2 supplement):7.
2. Tuttle TM. Management of the contralateral breast in women with breast cancer. Cancer Res. 2009;69 (Suppl.)(2):62s.
3. Throckmorton AD, Esserman LJ. When informed, all women do not prefer breast conservation. J Clin Oncol. 2009;27(4):484-6.
4. Sorbero ME, Dick AW, Beckjord EB, Ahrendt G. Diagnostic breast magnetic resonance imaging and contralateral prophylactic mastectomy. Ann Surg Oncol. 2009;16(6):1597-605.
5. Meijers-Heijboer H, van Geel B, van Putten WL, et al. Breast cancer after prophylactic bilateral mastectomy in women with a BRCA1 or BRCA2 mutation. N Engl J Med. 2001;345(3): 159-64. (Pubitemid 32662123)
6. Tuttle TM. Magnetic resonance imaging and contralateral prophylactic mastectomy: The "no mas" effect? Ann Surg Oncol. 2009 16 6 1461-2.
7. Press N, Reynolds S, Pinsky L, et al. 'That's like chopping off a finger because you're afraid it might get broken': Disease and illness in women's views of prophylactic mastectomy. Soc Sci Med. 2005;61(5):1106-17. (Pubitemid 40805554)
8. Stolier AJ, Fuhrman GM, Mauterer L, et al. Initial experience with surgical treatment planning in the newly diagnosed breast cancer patient at high risk for BRCA-1 or BRCA-2 mutation. Breast J. 2004;10(6):475-80. (Pubitemid 39524978)
9. Schwartz MD, Lerman C, Brogan B, et al. Impact of BRCA1/ BRCA2 counseling and testing on newly diagnosed breast cancer patients. J Clin Oncol. 2004;22(10):1823-9. (Pubitemid 41095172)
10. Weitzel JN, McCaffrey SM, Nedelcu R, et al. Effect of genetic cancer risk assessment on surgical decisions at breast cancer diagnosis. Arch Surg. 2003;138(12):1323-8; discussion 1329.
11. Metcalfe KA, Narod SA. Breast cancer risk perception among women who have undergone prophylactic bilateral mastectomy. J Natl Cancer Inst. 2002;94(20):1564-9. (Pubitemid 35277280)
12. Tuttle TM, Habermann EB, Grund EH, et al. Increasing use of contralateral prophylactic mastectomy for breast cancer patients: A trend toward more aggressive surgical treatment. J Clin Oncol. 2007 25 33 5203-9. (Pubitemid 350232251)
13. Metcalfe KA, Lubinski J, Ghadirian P, et al. Predictors of contralateral prophylactic mastectomy in women with a BRCA1 or BRCA2 mutation: The Hereditary Breast Cancer Clinical Study Group. J Clin Oncol. 2008;26(7):1093-7.